Cheryl Zimberlin

Venture Capital, Corporate Venture Capital, Investor · Netherlands

Cheryl Zimberlin is a venture capital investor and corporate venture capital investor based in the Netherlands. They invest in Health Care, Consumer Goods, Infrastructure and Life Science, typically at the Seed stage. Their portfolio includes FoRx Therapeutics, Micropsi Industries, Indi Molecular and Biolinq and 48 other companies.

Investment stages

Industries

Portfolio companies (52)

Similar investors in Health Care

  • Boyd RuttenVerified

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma

    Contact details available

  • Pieter de Jong

    Private Equity Firm · Netherlands

    Health CareWearablesE-commerceLeisure

    Portfolio: Everis Group, Carbonite

    Contact details available

  • Bart Hoeflaak

    Venture Capital · Netherlands

    Health CareE-commerceConsumer GoodsSearch Engine Optimization (SEO)

    Portfolio: Textmetrics, Pepscope

    Contact details available

  • Peter van Gelderen

    Venture Capital, Corporate Venture Capital · Netherlands

    Pollution ControlHealth CareConsumer GoodsEnergy

    Portfolio: Innosolids, Squirro

    Contact details available

  • Pieter Rhemrev

    Venture Capital · Netherlands

    Health CareE-commerceConsumer GoodsSearch Engine Optimization (SEO)

    Portfolio: Textmetrics, Pepscope

    Contact details available

  • Sander Verbrugge

    Venture Capital, Private Equity Firm · Netherlands

    Health CareCommercialTelecommunicationsHospitals

    Portfolio: FUMI Ingredients, Axign

    Contact details available

  • Ronald KemmerenVerified

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesEvents ServicesPayments

    Portfolio: Cotesa, Airborne Technology

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma

    Contact details available